Cited by 473Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsGenetic Associations and Epidemiology

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

Wilson, Peter W. F.·1994·JAMA

DOI 10.1001/jama.1994.03520210050031

Open this paper in CoChat — free account

Abstract

Objective To describe the association between apolipoprotein E alleles (epsilon 2, epsilon 3, and epsilon 4), dyslipidemias, and coronary heart disease (CHD). Design Cross-sectional prevalence study. Setting and participants Community-based sample of men (n = 1034) and women (n = 916) aged 40 to 77 years who are participating in a long-term study of cardiovascular disease. Study participants underwent fasting lipid measurements, coronary risk factor determinations, and a comprehensive evaluation for the presence of current or previous CHD. Results Compared with the epsilon 3 allele, the epsilon 4 allele was associated with elevated low-density lipoprotein cholesterol values (> or = 4.14 mmol/L [160 mg/dL]) in women, the epsilon 2 and epsilon 4 alleles were associated with moderately elevated triglyceride values (> or = 2.82 mmol/L [250 mg/dL]) in men, and the epsilon 2 allele was associated with severely elevated triglyceride values (> or = 5.64 mmol/L [500 mg/dL]) in men. The apolipoprotein E alleles were not associated with hypertension, obesity, smoking, or diabetes, but the epsilon 4 allele frequency was reduced in women after 60 years of age. The age-adjusted prevalence of CHD was associated with the epsilon 4 allele in both men (relative odds = 1.53, P = .04) and women (relative odds = 1.99, P = .05). In analyses for women and for both sexes combined, this relation persisted after adjustment by hypertension, smoking, obesity, diabetes, high-density lipoprotein cholester…

Integrity signals

Registry

Crossref · 10.1001/jama.1994.03520210050031

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,154
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363

Show all 59 references

Sorted by citations

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,708
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
Distinct patterns of brain activity in young carriers of the APOE -ε4 allele
Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., Matthews, P. M., Beckmann, C. F., & Mackay, C. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811879106 · Cited by 1,613
Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Genetic analysis of ageing: role of oxidative damage and environmental stresses
Martin, G. M., Austad, S. N., & Johnson, T. E. (1996) · Nature Genetics · doi:10.1038/ng0596-25 · Cited by 646
Apolipoprotein E Alleles and Risk of Coronary Disease: A Meta-analysis
Wilson, P. W. F., Schaefer, E. J., Larson, M. G., & Ordovas, J. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.10.1250 · Cited by 539
Self-citation
The role of cerebral ischemia in Alzheimer’s disease
Kalaria, R. N. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00125-1 · Cited by 526
Apolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral Hemorrhage
O’Donnell, H. C., Rosand, J. M., Knudsen, K. A., Furie, K. L., Segal, A. Z., Chiu, R. I., Ikeda, D., & Greenberg, S. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001273420403 · Cited by 505
ApoE-4 and Age at Onset of Alzheimer's Disease: The NIMH Genetics Initiative
Blacker, D., Haines, J. L., Rodes, L., Terwedow, H., Go, R. C. P., Harrell, L. E., Perry, R. T., Bassett, S. S., Chase, G., Meyers, D., et al. (1997) · Neurology · doi:10.1212/wnl.48.1.139 · Cited by 479
Overlap Between Pathology of Alzheimer Disease and Vascular Dementia
Kalaria, R. N., & Ballard, C. G. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199912003-00017 · Cited by 475
Lipoproteins, nutrition, and heart disease
Schaefer, E. J. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.2.191 · Cited by 436
Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study
Bruce, I. N., Urowitz, M. B., Gladman, D. D., Ibañez, D., & Steiner, G. A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11296 · Cited by 395
Lipids, risk factors and ischaemic heart disease
Castelli, W. P. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05851-0 · Cited by 337
The NIH Cognitive and Emotional Health Project: Report of the Critical Evaluation Study Committee
Hendrie, H. C., Albert, M. S., Butters, M. A., Gao, S., Knopman, D. S., Launer, L. J., Yaffe, K., Cuthbert, B. N., Edwards, E., & Wagster, M. V. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.11.004 · Cited by 323
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study
Lahoz, C., Schaefer, E. J., Cupples, L. A., Wilson, P. W. F., Levy, D. A., Osgood, D. P., Parpos, S., Pedro‐Botet, J., Daly, J. A., & Ordovás, J. M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00570-0 · Cited by 319
Self-citation
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Lewczuk, P., Riederer, P. F., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramírez, A., Parnetti, L., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 318
Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health Study
Kuller, L. H., Shemanski, L. R., Manolio, T. A., Haan, M. N., Fried, L. P., Bryan, R. N., Burke, G. L., Tracy, R. P., & Bhadelia, R. A. (1998) · Stroke · doi:10.1161/01.str.29.2.388 · Cited by 313
Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
Doherty, T. M., Fitzpatrick, L. A., Inoue, D., Qiao, J.-H., Fishbein, M. C., Detrano, R., Shah, P. K., & Rajavashisth, T. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0015 · Cited by 299
Do age-related macular degeneration and cardiovascular disease share common antecedents?
Snow, K. K., & Seddon, J. M. (1999) · Ophthalmic Epidemiology · doi:10.1076/opep.6.2.125.1558 · Cited by 276
Statement on Use of Apolipoprotein E Testing for Alzheimer Disease
Farrer, L. A. (1995) · JAMA · doi:10.1001/jama.1995.03530200063039 · Cited by 271
APOE genotype as a risk factor for ischemic cerebrovascular disease
McCarron, M. O., DeLong, D. M., & Alberts, M. J. (1999) · Neurology · doi:10.1212/wnl.53.6.1308 · Cited by 270
Similarities between Alzheimer's disease and vascular dementia
Kalaria, R. N. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00256-3 · Cited by 261
Apolipoprotein E ε4 Is Associated With the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid Angiopathy
Greenberg, S. M., Briggs, M. E., Hyman, B. T., Kokoris, G. J., Takis, C. E., Kanter, D. S., Kase, C. S., & Pessin, M. S. (1996) · Stroke · doi:10.1161/01.str.27.8.1333 · Cited by 259
Why are stroke patients prone to develop dementia?
Pasquier, F., & Leys, D. (1997) · Journal of Neurology · doi:10.1007/s004150050064 · Cited by 255
Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women.
Payami, H., Zareparsi, S., Montee, K. R., Sexton, G. J., Kaye, J. A., Bird, T. D., Yu, C. E., Wijsman, E. M., Heston, L. L., Litt, M. J., et al. (1996) · PubMed Central · Cited by 248
Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease?
Sparks, D. L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48466.x · Cited by 244
Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
Leonenko, G., Baker, E. A., Stevenson‐Hoare, J. O., Sierksma, A. S. R., Fiers, M. W. E. J., Williams, J. H., Strooper, B. D., & Escott‐Price, V. (2021) · Nature Communications · doi:10.1038/s41467-021-24082-z · Cited by 233
Stroke risk profile, brain volume, and cognitive function
Seshadri, S. S., Wolf, P. A., Beiser, A., Elias, M. F., Au, R., Kase, C. S., D’Agostino, R. B., & DeCarli, C. S. (2004) · Neurology · doi:10.1212/01.wnl.0000142968.22691.70 · Cited by 231
Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways
Zhao, N., Ren, Y., Yamazaki, Y., Qiao, W., Li, F., Felton, L. M., Mahmoudiandehkordi, S., Kueider-Paisley, A., Sonoustoun, B., Arnold, M., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.02.034 · Cited by 225
Genetics of Alzheimer’s Disease
Chouraki, V. A., & Seshadri, S. S. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800149-3.00005-6 · Cited by 220
ApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype
Minihane, A. M., Khan, S., Leigh-Firbank, E. C., Talmud, P., Wright, J. W., Murphy, M. C., Griffin, B. A., & Williams, C. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1990 · Cited by 215
Apolipoprotein E and atherosclerosis: insight from animal and human studies
Davignon, J., Cohn, J. S., Mabile, L., & Bernier, L. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00097-2 · Cited by 210
The Blood‐Brain Barrier and Cerebrovascular Pathology in Alzheimer's Disease
Kalaria, R. N. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07821.x · Cited by 196
Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study
O’Dwyer, L., Lamberton, F., Matura, S., Tanner, C. J., Scheibe, M., Miller, J., Rujescu, D., Prvulovic, D., & Hampel, H. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048895 · Cited by 199
Cognitive Performance in Hypertensive and Normotensive Older Subjects
Harrington, F., Saxby, B. K., McKeith, I. G., Wesnes, K. A., & Ford, G. A. (2000) · Hypertension · doi:10.1161/01.hyp.36.6.1079 · Cited by 195
Differential effects of the APOE genotype on brain function across the lifespan
Filippini, N., Ebmeier, K. P., MacIntosh, B. J., Trachtenberg, A. J., Frisoni, G. B., Wilcock, G. K., Beckmann, C. F., Smith, S. M., Matthews, P. M., & Mackay, C. E. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.08.009 · Cited by 195
EPIDEMIOLOGY OF DEMENTIA
Kukull, W. A., & Ganguli, M. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70233-4 · Cited by 194
Lower low‐density lipoprotein cholesterol levels are associated with Parkinson's disease
Huang, X., Chen, H., Miller, W. C., Mailman, R. B., Woodard, J. L., Chen, P., Xiang, D., Murrow, R. W., Wang, Y., & Poole, C. (2006) · Movement Disorders · doi:10.1002/mds.21290 · Cited by 190
Relative Risk of Alzheimer Disease and Age-at-Onset Distributions, Based on APOE Genotypes among Elderly African Americans, Caucasians, and Hispanics in New York City
Tang, M. X., Maestre, G. E., Tsai, W., Liu, X., Feng, L., Chung, W.-Y., Chun, M. R., Schofield, P. R., Stern, Y., Tycko, B., et al. (1996) · PubMed Central · doi:10.7916/d80v9r96 · Cited by 184
Status of Risk Factors for Vascular Dementia
Skoog, I. G. (1998) · Neuroepidemiology · doi:10.1159/000026147 · Cited by 177
APOE genotype, plasma lipids, lipoproteins, and AD in community elderly
Romas, S. N., Tang, M.-X., Berglund, L., & Mayeux, R. P. (1999) · Neurology · doi:10.1212/wnl.53.3.517 · Cited by 176
Age-Dependent Association of Apolipoprotein E Genotype With Coronary and Aortic Atherosclerosis in Middle-Aged Men
Ilveskoski, E., Perola, M., Lehtimäki, T. J., Laippala, P. J., Savolainen, V. T., Pajarinen, J., Penttilä, A., Lalu, K. H., Männikkö, A., Liesto, K. K., et al. (1999) · Circulation · doi:10.1161/01.cir.100.6.608 · Cited by 172
Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review
Chui, H. C., Zheng, L., Reed, B., Vinters, H. V., & Mack, W. J. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt98 · Cited by 145
Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors
Hirashiki, A., Yamada, Y., Murase, Y., Suzuki, Y., Kataoka, H., Morimoto, Y., Tajika, T., Murohara, T., & Yokota, M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)01062-3 · Cited by 135
Effect of Age, Ethnicity, and Head Injury on the Association between APOE Genotypes and Alzheimer's Disease
TANG, M., Maestre, G. E., TSAI, W., Liu, X., FENG, L., Chung, W., Chun, M. R., Schofield, P. W., Stern, Y., Tycko, B., et al. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32593.x · Cited by 135
Apolipoprotein E Polymorphisms Predict Low Density Lipoprotein Cholesterol Levels and Carotid Artery Wall Thickness but Not Incident Coronary Heart Disease in 12,491 ARIC Study Participants
Volcik, K. A., Barkley, R. A., Hutchinson, R. G., Mosley, T. H., HEISS, G. M., Sharrett, A. R., Ballantyne, C. M., & Boerwinkle, E. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj202 · Cited by 135
The apolipoprotein E gene, attention, and brain function.
Parasuraman, R., Greenwood, P. M., & Sunderland, T. (2002) · Neuropsychology · doi:10.1037//0894-4105.16.2.254 · Cited by 134
Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study
Corella, D., Tucker, K. L., Lahoz, C., Coltell, Ó., Cupples, L. A., Wilson, P. W. F., Schaefer, E. J., & Ordovás, J. M. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.4.736 · Cited by 130
Self-citation
An update on coronary risk factors
Kannel, W. B., & Wilson, P. W. F. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30016-5 · Cited by 128
Self-citation
ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation
Minihane, A. M., Jofre‐Monseny, L., Olano-Martin, E., & Rimbach, G. H. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005435 · Cited by 128
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study
Russo, G. T., Meigs, J. B., Cupples, L. A., Demissie, S., Otvos, J. D., Wilson, P. W. F., Lahoz, C., Cucinotta, D., Couture, P., Mallory, T., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00409-9 · Cited by 125
Self-citation
Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu‐Asia Aging Study
Huang, X., Abbott, R. D., Petrovitch, H., Mailman, R. B., & Ross, G. W. (2008) · Movement Disorders · doi:10.1002/mds.22013 · Cited by 124
Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: A systematic in-depth review
Boes, E., Coassin, S., Kollerits, B., Heid, I. M., & Kronenberg, F. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.11.003 · Cited by 122
Biologic markers as predictors of cardiovascular disease
Frishman, W. H. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00184-3 · Cited by 120
The relationship between blood pressure and dementia: a review
Skoog, I. G. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)89428-0 · Cited by 119
Rapid Identification of Apolipoprotein E Genotypes by Multiplex Amplification Refractory Mutation System PCR and Capillary Gel Electrophoresis
Donohoe, G. G., Salomäki, A., Lehtimäki, T. J., Pulkki, K. J., & Kairisto, V. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.1.143 · Cited by 118
Polymorphism of the Apolipoprotein E Gene and Early Carotid Atherosclerosis Defined by Ultrasonography in Asymptomatic Adults
Cattin, L., Fisicaro, M., Tonizzo, M., Valenti, M., Danek, G. M., Fonda, M., Col, P. G. D., Casagrande, S., Pincetti, E., Bovenzi, M., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.91 · Cited by 114
Apolipoprotein E and Progression of Chronic Kidney Disease
Hsu, C. C.-C. (2005) · JAMA · doi:10.1001/jama.293.23.2892 · Cited by 110
Rapid Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of ApoE in ApoE-Deficient Mice
Tsukamoto, K., Tangirala, R. K., Chun, S. H., Puré, E., & Rader, D. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.9.2162 · Cited by 110
Polymorphisms of the Apolipoprotein E Gene and Severity of Coronary Artery Disease Defined by Angiography
Wang, X. L., McCredie, R. M., & Wilcken, D. E. L. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1030 · Cited by 110
Association Between Severe Cerebral Amyloid Angiopathy and Cerebrovascular Lesions in Alzheimer Disease Is Not a Spurious One Attributable to Apolipoprotein E4
Olichney, J., Hansen, L. A., Hofstetter, C. R., Lee, J. H., Katzman, R., & Thal, L. J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.869 · Cited by 110
Association Between Apolipoprotein E Genotype and Alzheimer Disease in African American Subjects
Graff‐Radford, N. R., Green, R. C., Go, R. C. P., Hutton, M. L., Edeki, T. I., Bachman, D., Adamson, J. L., Griffith, P. A., Willis, F. B., Williams, M. P., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.4.594 · Cited by 109
APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies.
Araki, S., Moczulski, D. K., Ficociello, L., Scott, L. J., Warram, J. H., & Królewski, A. S. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2190 · Cited by 109
Obesity Modulates the Association among APOE Genotype, Insulin, and Glucose in Men
Elosúa, R., Demissie, S., Cupples, L. A., Meigs, J. B., Wilson, P. W. F., Schaefer, E. J., Corella, D., & Ordovás, J. M. (2003) · Obesity Research · doi:10.1038/oby.2003.201 · Cited by 108
Self-citation
Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies.
Bonnet, F., & Cooper, M. E. (2000) · PubMed · Cited by 106
APOE polymorphism and lipid profile in three ethnic groups in the Singapore population
Tan, C. E., Tai, E. S., Tan, C. S., Chia, K. S., Lee, J., Chew, S. K., & Ordovás, J. M. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00232-6 · Cited by 105
The Blood–Brain Barrier in Alzheimer's Disease
Sharma, H. S., Castellani, R. J., Smith, M. A., & Sharma, A. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00003-x · Cited by 105
Statin therapy in Alzheimer's disease
Sparks, D. L., Sabbagh, M., Connor, D. J., Soares, H. D., Lopez, J., Stankovic, G. R., Johnson‐Traver, S., Ziolkowski, C. H. J., & Browne, P. J. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00689.x · Cited by 104
Distributions of ACE and APOE Polymorphisms and Their Relations With Dementia Status in Korean Centenarians
Choi, Y. H., Kim, J.-H., Kim, D. K., Kim, J.-W., Kim, D., Lee, M. S., Kim, C. H., & Park, S. C. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.3.m227 · Cited by 103
Association of Apo E Polymorphism With Plasma Lipid Levels in a Multiethnic Elderly Population
Pablos-Méndez, A., Mayeux, R. P., Ngai, C. I., Shea, S., & Berglund, L. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3534 · Cited by 102
Association between levels of serum perfluorooctane sulfate and carotid artery intima–media thickness in adolescents and young adults
Lin, C., Lin, L., Wen, T.-W., Lien, G., Chien, K., Hsu, S. H.-J., Liao, C., Sung, F.-C., Chen, P., & Su, T. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.042 · Cited by 101
Association of APOE genotype with carotid atherosclerosis in men and women
Elosua, R., Ordovas, J. M., Cupples, L. A., Fox, C. S., Polak, J. F., Wolf, P. A., D’Agostino, R. A., & O’Donnell, C. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400114-jlr200 · Cited by 101
Polymorphisms in the PON gene cluster are associated with Alzheimer disease
Erlich, P. M., Lunetta, K. L., Cupples, L. A., Huyck, M., Green, R. C., Baldwin, C. T., & Farrer, L. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi428 · Cited by 101
Low Cholesterol as a Risk Factor for Primary Intracerebral Hemorrhage: A Case-Control Study
Segal, A. Z., Chiu, R. I., Eggleston-Sexton, P. M., Beiser, A., & Greenberg, S. M. (1999) · Neuroepidemiology · doi:10.1159/000026210 · Cited by 100
Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele.
Bergeron, N., & Havel, R. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118408 · Cited by 100
Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study
Ou, T.-L. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00244-x · Cited by 96
The Apolipoprotein E ε4 Allele Increases the Odds of Chronic Cerebral Infarction Detected at Autopsy in Older Persons
Schneider, J. A., Bienias, J. L., Wilson, R. S., Berry‐Kravis, E., Evans, D. A., & Bennett, D. A. (2005) · Stroke · doi:10.1161/01.str.0000160747.27470.2a · Cited by 96
Small Concomitant Vascular Lesions Do Not Influence Rates of Cognitive Decline in Patients With Alzheimer Disease
Lee, J. H., Olichney, J., Hansen, L. A., Hofstetter, C. R., & Thal, L. J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1474 · Cited by 95
Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype
Frikke‐Schmidt, R., Nordestgaard, B. G., Agerholm-Larsen, B., Schnohr, P., & Tybjærg‐Hansen, A. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31975-1 · Cited by 94
Apolipoprotein E and renal disease
Liberopoulos, E. N., Siamopoulos, K. C., & Elisaf, M. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.10.013 · Cited by 94
The APOE Gene and Differences in Life Expectancy in Europe
Ewbank, D. (2004) · The Journals of Gerontology Series A · doi:10.1093/gerona/59.1.b16 · Cited by 94
Chapter 2 Genetics of the Framingham Heart Study Population
Govindaraju, D. R., Cupples, L. A., Kannel, W. B., O’Donnell, C. J., Atwood, L. D., D’Agostino, R. B., Fox, C. S., Larson, M., Levy, D. A., Murabito, J. M., et al. (2008) · Advances in genetics · doi:10.1016/s0065-2660(08)00602-0 · Cited by 94
Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization
Segall, M. L., Dhanasekaran, P., Baldwin, F., Anantharamaiah, G. M., Weisgraber, K. H., Phillips, M. C., & Lund‐Katz, S. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200157-jlr200 · Cited by 93
A Review on Blood Pressure and Ischaemic White Matter Lesions
Skoog, I. G. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051184 · Cited by 93
Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.
Tsukamoto, K., Smith, P., Glick, J. M., & Rader, D. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119501 · Cited by 92
Apolipoprotein E genotypes and response of plasma lipids and progression–regression of coronary atherosclerosis to lipid-lowering drug therapy
Ballantyne, C. M., Herd, J. A., Stein, E. A., Ferlic, L. L., Dunn, J. K., Gotto, A. M., & Marian, A. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00918-9 · Cited by 92
Prevalence of Apolipoprotein E Alleles in Healthy Subjects and Survivors of Ischemic Stroke
Margaglione, M., Seripa, D., Gravina, C., Grandone, E., Vecchione, G., Cappucci, G., Merla, G., Papa, S., Postiglione, A., Minno, G. D., et al. (1998) · Stroke · doi:10.1161/01.str.29.2.399 · Cited by 87
Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM
Kimura, H., Suzuki, Y., Gejyo, F., Karasawa, R., Miyazaki, R., Suzuki, S., & Arakawa, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531184 · Cited by 85
Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases
Alagarsamy, J., Jaeschke, A., & Hui, D. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179892 · Cited by 86
Association of APOEpolymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study
Chu, A. Y., Parekh, R. S., Astor, B. C., Coresh, J., Berthier‐Schaad, Y., Smith, M. W., Shuldiner, A. R., & Kao, W. H. L. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-108 · Cited by 85
APOE Genotype, Lipids, and Coronary Heart Disease Risk
Ward, H. A., Mitrou, P. N., Bowman, R., Luben, R., Wareham, N. J., Khaw, K., & Bingham, S. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.234 · Cited by 84
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases
Xu, P., Li, D., Tang, X., Bao, X., Huang, J., Tang, Y., Yang, Y., Xu, H., & Fan, X. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8461-3 · Cited by 84
Initial results of a genome survey for novel alzheimer's disease risk genes: association with a locus on the X chromosome
Zubenko, G. S., Stiffler, J. S., Hughes, H. B., Hurtt, M. R., & Kaplan, B. B. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980207)81:1 · Cited by 29
Bias due to missing exposure data using complete‐case analysis in the proportional hazards regression model
Demissie, S., LaValley, M. P., Horton, N. J., Glynn, R. J., & Cupples, L. A. (2003) · Statistics in Medicine · doi:10.1002/sim.1340 · Cited by 83
APOE-related mortality: Effect of dementia, cardiovascular disease and gender
Rosvall, L., Rizzuto, D., Wang, H., Winblad, B. G., Graff, C., & Fratiglioni, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.003 · Cited by 82
Lipids and diabetic nephropathy
Rosario, R. F., & Prabhakar, S. S. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0079-7 · Cited by 82
Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia
Bertolini, S., Pisciotta, L., Scala, L. D., Langheim, S., Bellocchio, A., Masturzo, P., Cantàfora, A., Martini, S., Averna, M. R., Pes, G. M., et al. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.12.037 · Cited by 81
DIABETES MELLITUS AND CORONARY HEART DISEASE
Wilson, P. W. F. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70219-x · Cited by 81
Self-citation
Environmental factors modulate the effect of the APOE genetic polymorphism on plasma lipid concentrations: Ecogenetic studies in a Mediterranean Spanish population
Corella, D., Guillén, M., Saacuteiz, C., Portoleacutes, O., Martínez‐Sabater, A., Cortina, S. H. M., Folch, J., Gonz[aacute]lez, J. I., & Ordovás, J. M. (2001) · Metabolism · doi:10.1053/meta.2001.24867 · Cited by 77
Association of Apolipoprotein ε2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM
Chowdhury, T. A., Dyer, P., Kumar, S., Gibson, S. P., Rowe, B. R., Davies, S., Marshall, S. M., Morris, P. J., Gill, G. V., Feeney, S. A., et al. (1998) · Diabetes · doi:10.2337/diab.47.2.278 · Cited by 77

Authors: Wilson, P. W. F.
Corresponding author: Wilson, Peter W. F.
ORCID: Wilson, Peter W. F.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 1994-12-07
Volume: 272
Issue: 21
Pages: 1666
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1994.03520210050031
OpenAlex: W4237709179
Cited by: 468
References: 59
Citations by year: 2025: 1 · 2024: 3 · 2023: 10 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 2 · 2017: 6 · 2016: 7 · 2015: 7 · 2014: 7 · 2013: 14 · 2012: 9
FWCI: 21.68
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: apolipoprotein E, apolipoprotein E ε4 allele, dyslipidemia, coronary artery disease, LDL cholesterol, triglycerides, sex differences, genetic risk factors, Framingham Offspring Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks